{"id":"https://openalex.org/W2116633865","doi":"https://doi.org/10.1177/1759720x13485328","title":"Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential","display_name":"Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential","alternate_titles":[],"publication_year":2013,"publication_date":"2013-05-23","ids":{"openalex":"https://openalex.org/W2116633865","doi":"https://doi.org/10.1177/1759720x13485328","mag":"2116633865","pmid":"https://pubmed.ncbi.nlm.nih.gov/23858337","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3707345"},"language":"en","primary_location":{"id":"doi:10.1177/1759720x13485328","doi":"https://doi.org/10.1177/1759720x13485328","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1759720x13485328","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/1759720X13485328","source":{"id":"https://openalex.org/S138391592","display_name":"Therapeutic Advances in Musculoskeletal Disease","issn_l":"1759-720X","issn":["1759-720X","1759-7218"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Musculoskeletal Disease","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2116633865"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/1759720X13485328","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103792230","display_name":"Herbert L. Kellner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Herbert Kellner","raw_affiliation_strings":["Department of Rheumatology, Hospital Neuwittelsbach, Romanstr. 9, 80639 Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Hospital Neuwittelsbach, Romanstr. 9, 80639 Munich, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5103792230"],"corresponding_institution_ids":[],"apc_list":{"value":2650,"currency":"USD","value_usd":2650},"apc_paid":null,"fwci":11.143,"has_fulltext":true,"cited_by_count":117,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.99068007,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"5","issue":"3","first_page":"141","last_page":"152"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-17a","display_name":"IL-17A","score":0.9919999837875366},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9779999852180481},{"id":"https://openalex.org/keywords/secukinumab","display_name":"secukinumab","score":0.9860000014305115},{"id":"https://openalex.org/keywords/ixekizumab","display_name":"ixekizumab","score":1.0},{"id":"https://openalex.org/keywords/brodalumab","display_name":"brodalumab","score":1.0},{"id":"https://openalex.org/keywords/synovitis","display_name":"synovitis","score":0.8889999985694885},{"id":"https://openalex.org/keywords/joint-damage","display_name":"joint destruction","score":0.9070000052452087},{"id":"https://openalex.org/keywords/synovial-fluid-biomarkers","display_name":"synovial fluid biomarkers","score":0.7509999871253967},{"id":"https://openalex.org/keywords/il-17-receptor","display_name":"IL-17 receptor","score":0.5350000262260437},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.75},{"id":"https://openalex.org/keywords/anti-inflammatory-therapy","display_name":"anti-inflammatory therapy","score":0.36500000953674316}],"concepts":[{"id":"https://openalex.org/C2779786854","wikidata":"https://www.wikidata.org/wiki/Q7444755","display_name":"Secukinumab","level":4,"score":0.9769638776779175},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9228321313858032},{"id":"https://openalex.org/C2779745271","wikidata":"https://www.wikidata.org/wiki/Q13574436","display_name":"Ixekizumab","level":5,"score":0.8332487940788269},{"id":"https://openalex.org/C47348012","wikidata":"https://www.wikidata.org/wiki/Q99486570","display_name":"Interleukin 17","level":3,"score":0.7979004383087158},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.7763365507125854},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4765473008155823},{"id":"https://openalex.org/C2780550940","wikidata":"https://www.wikidata.org/wiki/Q502730","display_name":"Cartilage","level":2,"score":0.46491676568984985},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.464573472738266},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.43825310468673706},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.42421141266822815},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.423772394657135},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4198080003261566},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3759288489818573},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.3403198719024658},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.3164478838443756},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.2951265871524811},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1822049915790558},{"id":"https://openalex.org/C105702510","wikidata":"https://www.wikidata.org/wiki/Q514","display_name":"Anatomy","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1177/1759720x13485328","doi":"https://doi.org/10.1177/1759720x13485328","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1759720x13485328","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/1759720X13485328","source":{"id":"https://openalex.org/S138391592","display_name":"Therapeutic Advances in Musculoskeletal Disease","issn_l":"1759-720X","issn":["1759-720X","1759-7218"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Musculoskeletal Disease","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2706457","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3707345","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3707345","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3707345/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Adv Musculoskelet Dis","raw_type":"Text"},{"id":"pmid:23858337","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23858337","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic advances in musculoskeletal disease","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1177/1759720x13485328","doi":"https://doi.org/10.1177/1759720x13485328","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1759720x13485328","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/1759720X13485328","source":{"id":"https://openalex.org/S138391592","display_name":"Therapeutic Advances in Musculoskeletal Disease","issn_l":"1759-720X","issn":["1759-720X","1759-7218"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Musculoskeletal Disease","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307778","display_name":"Novartis","ror":"https://ror.org/02f9zrr09"},{"id":"https://openalex.org/F4320332736","display_name":"Novartis Pharma","ror":"https://ror.org/0013shd50"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2116633865.pdf","grobid_xml":"https://content.openalex.org/works/W2116633865.grobid-xml"},"referenced_works_count":73,"referenced_works":["https://openalex.org/W1508752722","https://openalex.org/W1543653831","https://openalex.org/W1553271826","https://openalex.org/W1805155421","https://openalex.org/W1856119395","https://openalex.org/W1911161962","https://openalex.org/W1967097218","https://openalex.org/W1971892512","https://openalex.org/W1987032872","https://openalex.org/W1987628377","https://openalex.org/W1994813456","https://openalex.org/W2000086986","https://openalex.org/W2006249161","https://openalex.org/W2007794162","https://openalex.org/W2008783725","https://openalex.org/W2012680181","https://openalex.org/W2014785961","https://openalex.org/W2015215846","https://openalex.org/W2016287743","https://openalex.org/W2020233428","https://openalex.org/W2024173356","https://openalex.org/W2024490058","https://openalex.org/W2025035158","https://openalex.org/W2034453891","https://openalex.org/W2039416679","https://openalex.org/W2042586707","https://openalex.org/W2043112612","https://openalex.org/W2046388159","https://openalex.org/W2065136791","https://openalex.org/W2068040573","https://openalex.org/W2074494782","https://openalex.org/W2076456688","https://openalex.org/W2077492907","https://openalex.org/W2085318733","https://openalex.org/W2090372920","https://openalex.org/W2091653067","https://openalex.org/W2092602103","https://openalex.org/W2100564391","https://openalex.org/W2103177978","https://openalex.org/W2107235439","https://openalex.org/W2107583569","https://openalex.org/W2108271686","https://openalex.org/W2108768628","https://openalex.org/W2109955020","https://openalex.org/W2110826367","https://openalex.org/W2112128505","https://openalex.org/W2114982159","https://openalex.org/W2115055179","https://openalex.org/W2120989550","https://openalex.org/W2124995013","https://openalex.org/W2127834887","https://openalex.org/W2130420229","https://openalex.org/W2132079355","https://openalex.org/W2135808113","https://openalex.org/W2136357996","https://openalex.org/W2137866495","https://openalex.org/W2138882513","https://openalex.org/W2147843944","https://openalex.org/W2148251534","https://openalex.org/W2151209321","https://openalex.org/W2151440511","https://openalex.org/W2151566115","https://openalex.org/W2159788225","https://openalex.org/W2160258620","https://openalex.org/W2161415751","https://openalex.org/W2164082708","https://openalex.org/W2167061160","https://openalex.org/W2170811031","https://openalex.org/W2317046002","https://openalex.org/W2322390243","https://openalex.org/W2334285045","https://openalex.org/W2607079988","https://openalex.org/W4250753642"],"related_works":["https://openalex.org/W2008179404","https://openalex.org/W2288247518","https://openalex.org/W2030044728","https://openalex.org/W3005251815","https://openalex.org/W2329375242","https://openalex.org/W1883505709","https://openalex.org/W1964391698","https://openalex.org/W2892124666","https://openalex.org/W2022110678","https://openalex.org/W1924808736"],"abstract_inverted_index":{"Clinical":[0],"and":[1,29,34,43,57,107,109],"experimental":[2],"evidence":[3],"suggest":[4],"that":[5,60],"interleukin-17A":[6],"(IL-17A;":[7],"also":[8],"known":[9],"as":[10],"IL-17)":[11],"is":[12,129],"an":[13],"attractive":[14],"therapeutic":[15],"target":[16],"in":[17,32,46,54,77,121,138,145],"rheumatoid":[18],"arthritis":[19],"(RA).":[20],"Rheumatoid":[21],"synovial":[22,33,41,71],"tissue":[23],"produces":[24],"IL-17A,":[25],"which":[26],"causes":[27],"cartilage":[28],"bone":[30,35],"degradation":[31],"explants.":[36],"Overexpression":[37],"of":[38],"IL-17A":[39,64,73,87,99],"induces":[40],"inflammation":[42],"joint":[44],"destruction":[45],"animal":[47],"RA":[48,84],"models.":[49],"These":[50],"effects":[51],"are":[52,75],"attenuated":[53],"IL-17A-deficient":[55],"animals":[56],"by":[58],"agents":[59],"block":[61],"IL-17A.":[62],"Serum":[63],"levels":[65,74,88],"and,":[66],"to":[67,135,154],"a":[68,93],"greater":[69],"extent,":[70],"fluid":[72],"elevated":[76],"many":[78],"patients":[79,146],"with":[80,92,133,140],"RA.":[81],"In":[82],"some":[83],"cohorts,":[85],"higher":[86],"have":[89,118],"been":[90,119],"associated":[91],"more":[94],"severe":[95],"clinical":[96,124,136],"course.":[97],"Several":[98],"blockers,":[100],"including":[101],"the":[102,110,130],"anti-IL-17A":[103],"monoclonal":[104,115],"antibodies":[105],"secukinumab":[106,128],"ixekizumab,":[108],"anti-IL-17":[111],"receptor":[112],"subunit":[113],"A":[114],"antibody":[116],"brodalumab":[117],"evaluated":[120],"phase":[122,141],"II":[123],"trials.":[125],"Of":[126],"these,":[127],"most":[131],"advanced":[132],"respect":[134],"evaluation":[137],"RA,":[139],"III":[142],"trials":[143],"ongoing":[144],"on":[147],"background":[148],"methotrexate":[149],"who":[150],"had":[151],"inadequate":[152],"responses":[153],"previous":[155],"tumor":[156],"necrosis":[157],"factor":[158],"blocker":[159],"therapy.":[160]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2116633865","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":22},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
